V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220021008 | 220009534 | 1.69 | 60 | null | null | 2017-12-08 | FLA | 02 | N | 220036228 | VENETOCLAX |
| 220021009 | 220009542 | null | null | Curative (C) | 2019-02-03 | 2019-05-17 | Alemtuzumab + Cyclophos TBI Allo | null | null | 220036248 | FLUDARABINE |
| 220021010 | 220021928 | 1.75 | 86.2 | Curative (C) | 2017-07-09 | 2017-09-26 | Cetuximab 7 day (Cycle 1) | N | null | 220036280 | IPM |
| 220021011 | 220009558 | 1.81 | 108 | Curative (C) | 2017-08-11 | 2017-09-10 | Methotrexate High Dose (3g/m2) | N | null | 220036334 | EC |
| 220021012 | 220009560 | null | 9.7 | Curative (C) | 2016-11-13 | 2016-12-11 | Cytarabine+Methotrexate Intrathecal | null | N | 220036338 | CARBOPLATIN + CETUXIMAB + FU |
| 220021013 | 220009578 | 1.65 | null | Palliative (P) | 2018-07-15 | 2018-08-13 | BUSULFAN + FLUDARABINE | null | N | 220036432 | CETUXIMAB + CISPLATIN + FU |
| 220021014 | 220018225 | null | 45 | Curative (C) | 2017-03-14 | 2017-03-14 | Alemtuzumab + Cyclophos TBI Allo | null | N | 220036524 | ALEMTUZUMAB + CYCLOPHOSPHAMIDE |
| 220021016 | 220009608 | 1.83 | 86 | Curative (C) | 2018-05-18 | 2018-07-08 | Trabectedin | 01 | N | 220036563 | SPANISH MAINTENANCE |
| 220021017 | 220009620 | 1.75 | 86 | Curative (C) | 2014-08-22 | 2014-09-10 | MidAC | N | Y | 220036606 | DACTINOMYCIN |
| 220021018 | 220009626 | 0 | 62 | Curative (C) | 2016-03-24 | 2016-03-24 | ROMAZA TRIAL | N | null | 220036614 | DABRAFENIB |
| 220021019 | 220009631 | 1.75 | 82 | Palliative (P) | 2018-01-22 | 2018-02-07 | PEMBROLIZUMAB | N | N | 220036629 | FIGARO TRIAL |
| 220021020 | 220009641 | 1.65 | null | null | 2014-12-11 | 2014-12-11 | Etoposide oral | N | N | 220036641 | BUSULFAN + FLUDARABINE |
| 220021021 | 220009657 | 1.55 | 87.2 | null | 2017-12-16 | 2018-04-26 | Cladribine (subcut) 5 days | 02 | N | 220036675 | CODOX M |
| 220021022 | 220009660 | 1.24 | null | Palliative (P) | 2018-06-21 | 2018-06-22 | Arsenic trioxide | 02 | N | 220036683 | CYTARABINE IT + METHOTREXATE |
| 220021023 | 220009681 | null | 103 | Curative (C) | 2013-09-29 | 2013-10-13 | Cytarabine+Methotrexate Intrathecal | null | null | 220000653 | ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN |
| 220021024 | 220009684 | 1.3 | 75 | Palliative (P) | 2016-05-30 | 2016-05-31 | DHAP | 99 | null | 220002814 | CLOFARABINE + DAUNORUBICIN |
| 220021025 | 220009690 | 1.84 | 81.7 | Disease modification (D) | 2017-03-26 | 2017-05-05 | FIGARO TRIAL | N | N | 220004682 | CYTARABINE + MITOXANTRONE |
| 220021026 | 220009701 | 1.92 | 105.8 | Curative (C) | null | 2018-12-13 | ALL UKALL60+ TRIAL | 2 | N | 220014128 | CYTARABINE + MITOXANTRONE |
| 220021027 | 220009714 | 1.56 | 70 | Disease modification (D) | 2018-05-25 | 2018-05-25 | Carboplatin AUC 6 - 10 | 02 | N | 220018242 | MITOXANTRONE + TRETINOIN |
| 220021028 | 220009730 | null | null | Palliative (P) | 2015-08-13 | 2015-09-10 | Alemtuzumab + Cyclophos TBI Allo | N | N | 220021070 | EOX |
| 220021029 | 220009735 | 1.68 | 45.4 | Disease modification (D) | 2017-03-07 | 2017-03-12 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 220021758 | MITOXANTRONE + TRETINOIN |
| 220021030 | 220009743 | 1.67 | 80 | Palliative (P) | 2015-09-21 | 2015-10-19 | ALL UKALL2011 Maintenance A1 | 01 | null | 220022881 | IPO |
| 220021031 | 220020013 | 1.85 | null | Palliative (P) | 2015-09-29 | 2017-07-12 | DHAP - R | null | N | 220028838 | EOX |
| 220021032 | 220015147 | 1.55 | 94 | Palliative (P) | 2019-09-05 | 2019-09-17 | Arsenic Triox + Tretinoin Ind W1-4 | 02 | N | 220029686 | FIGARO TRIAL |
| 220021033 | 220009783 | 1.8 | 102.2 | null | 2017-11-29 | 2017-12-05 | INTERFERON | N | N | 220032124 | MITOXANTRONE + TRETINOIN |
| 220021034 | 220009785 | 1.75 | 45.4 | null | 2018-05-14 | 2018-11-01 | Irinotecan 14day | 02 | N | 220032395 | CAPECITABINE |
| 220021035 | 220018264 | null | 86.5 | Palliative (P) | 2018-09-24 | 2018-09-24 | PEMBROLIZUMAB | N | null | 220034024 | CETUXIMAB + CISPLATIN + FU |
| 220021036 | 220009795 | 1.69 | 41.2 | Curative (C) | null | 2014-03-28 | Cisplatin + Etoposide (3 day) | N | N | 220034048 | BUSULFAN + CYCLOPHOSPHAMIDE |
| 220021037 | 220009805 | 1.67 | 66.2 | Disease modification (D) | 2015-04-06 | 2015-04-13 | Etoposide oral | 2 | N | 220034508 | DABRAFENIB + TRAMETINIB |
| 220021038 | 220009813 | null | -1 | Curative (C) | 2017-08-15 | 2017-08-21 | BUSULFAN + FLUDARABINE | null | N | 220035216 | METHOTREXATE + PEGASPARGASE |
| 220021039 | 220009823 | 1.79 | 81.1 | Curative (C) | 2015-03-26 | 2015-04-04 | MA (Cytarabine 3g/m2) | N | N | 220020987 | TRASTUZUMAB |
| 220021040 | 220021040 | 1.72 | 89.5 | Palliative (P) | 2019-06-21 | 2019-07-23 | Atezolizumab | N | N | 220026545 | UKALL60+ |
| 220021041 | 220004061 | 0 | 124.75 | Disease modification (D) | null | 2016-11-10 | IMATINIB | N | N | 220000242 | IMATINIB |
| 220021043 | 220004070 | null | 0 | Disease modification (D) | 2017-05-07 | 2017-05-07 | IMATINIB | N | N | 220000450 | IMATINIB |
| 220021044 | 220012157 | 1.8 | 0 | Disease modification (D) | 2018-06-01 | 2018-11-30 | IMATINIB | N | N | 220000723 | IMATINIB |
| 220021045 | 220004085 | 1.75 | 0 | Disease modification (D) | 2017-07-01 | 2017-08-25 | IMATINIB | 02 | N | 220000807 | IMATINIB |
| 220021046 | 220004087 | 0 | 0 | Palliative (P) | 2017-09-09 | 2017-09-09 | Imatinib 400mg | N | N | 220001016 | IMATINIB |
| 220021047 | 220004091 | null | null | Curative (C) | 2010-04-11 | 2013-11-15 | IMATINIB | null | null | 220001105 | IMATINIB |
| 220021048 | 220016589 | null | 47 | Disease modification (D) | 2015-12-22 | 2017-05-07 | Imatinib 400mg | N | N | 220001130 | IMATINIB |
| 220021049 | 220004100 | 1.68 | null | Curative (C) | 2017-05-22 | 2017-07-04 | Imatinib 400mg | null | N | 220001182 | IMATINIB |
| 220021057 | 220004219 | 1.88 | 115 | Curative (C) | 2014-02-14 | 2014-03-14 | IMATINIB | null | N | 220003878 | IMATINIB |
| 220021058 | 220004236 | 1.65 | 49 | Disease modification (D) | 2017-05-30 | 2017-07-20 | Imatinib 400mg | 02 | N | 220004202 | IMATINIB |
| 220021059 | 220004244 | 1.77 | null | null | 2014-01-01 | 2014-09-28 | IMATINIB | N | N | 220004771 | IMATINIB |
| 220021061 | 220012236 | null | null | Curative (C) | 2016-04-26 | 2018-10-06 | Imatinib 400mg | null | null | 220004877 | IMATINIB |
| 220021062 | 220004289 | null | null | Palliative (P) | 2013-02-08 | 2014-06-15 | IMATINIB | null | null | 220005650 | IMATINIB |
| 220021064 | 220004330 | 0 | 0 | Curative (C) | null | 2014-07-04 | IMATINIB | N | N | 220007037 | IMATINIB |
| 220021065 | 220004333 | 0 | 0 | Palliative (P) | null | 2016-06-13 | IMATINIB | 2 | N | 220007069 | IMATINIB |
| 220021067 | 220004349 | 0 | null | null | 2014-01-25 | 2014-01-25 | Imatinib 400mg | N | N | 220007267 | IMATINIB |
| 220021068 | 220004353 | 1.77 | 70 | Palliative (P) | null | 2017-02-17 | Imatinib 400mg | N | N | 220007300 | IMATINIB |
| 220021069 | 220004364 | null | 0 | Palliative (P) | null | 2014-02-19 | IMATINIB | N | N | 220007575 | IMATINIB |